Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
Year: 2011
Type: review
Abstract: China has one of the highest carrier prevalences of hepatitis B virus (HBV) in the world: nearly 10% of the general population. The disease burden of HBV infection and hepatocellular carcinoma (HCC) is also believed to be among the world's largest, and that of hepatitis C virus (HCV) infection is likely to be substantial as well. However, the epidemiology and measures to control HBV and HCV infection in China remain relatively unknown outside the country. We review the epidemiology of HBV and HCV infection, the disease burden of and risk factors for HCC, and current control measures against HBV and HCV infection in China. We also discuss the relevant literature and implications for future studies of hepatitis and HCC in China.
Source: Journal of Epidemiology
Authors: Masahiro Tanaka, Francisco Katayama, Hideaki Kato, Hideo Tanaka, Jianbing Wang, You Lin Qiao, Manami Inoue
Institutions: Osaka City General Hospital, Osaka International Cancer Institute, The University of Tokyo, Nagoya City University, Aichi Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, National Cancer Center, National Cancer Center
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,356
OpenAlex ID: W2087642115
